Pulmonary metastasectomy for testicular germ cell tumors: A 28-year experience

被引:53
作者
Liu, D
Abolhoda, A
Burt, ME
Martini, N
Bains, MS
Downey, RJ
Rusch, VW
Bosl, GJ
Ginsberg, RJ
机构
[1] Mem Sloan Kettering Canc Ctr, Thorac Serv, Dept Surg, Genitourinary Oncol Serv,Div Solid Tumor Oncol, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
关键词
D O I
10.1016/S0003-4975(98)00940-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. The role of surgery in patients with pulmonary metastatic germ cell tumors has been evolving since the 1970s. To evaluate the results of pulmonary resection, we reviewed our 28-year experience. Methods. Between July 1967 and May 1995, 157 patients with testicular germ cell tumors underwent pulmonary resections for suspected metastases. Their clinical and pathological data were reviewed. Kaplan-Meier and Cox regression models were used to analyze prognostic factors for survival after resection of metastatic disease. Results. All patients were male with median age of 27 years (range 15-65). Complete resection was accomplished in 155 (99%) patients, viable carcinoma was present in 44% (70) of the patients. Forty-one (26%) patients had metastases to other sites after pulmonary metastasectomy. The overall actuarial survival 5 years after pulmonary resection was 68% for the entire group and 82% for patients diagnosed after 1985. On multivariate analysis, the adverse prognostic factors were metastases to nonpulmonary visceral sites (p = 0.0069) and the presence of viable carcinoma in the resected specimen (p < 0.0001). Conclusions. With current chemotherapy regimens, almost 85% of the patients with testicular germ cell tumors undergoing complete resection of their pulmonary metastases can be expected to achieve long-term survival. (C) 1998 by The Society of Thoracic Surgeons.
引用
收藏
页码:1709 / 1714
页数:6
相关论文
共 28 条
[1]  
BOSL GJ, 1988, CANCER RES, V48, P3524
[2]   A RANDOMIZED TRIAL OF ETOPOSIDE + CISPLATIN VERSUS VINBLASTINE + BLEOMYCIN + CISPLATIN + CYCLOPHOSPHAMIDE + DACTINOMYCIN IN PATIENTS WITH GOOD-PROGNOSIS GERM-CELL TUMORS [J].
BOSL, GJ ;
GELLER, NL ;
BAJORIN, D ;
LEITNER, SP ;
YAGODA, A ;
GOLBEY, RB ;
SCHER, H ;
VOGELZANG, NJ ;
AUMAN, J ;
CAREY, R ;
FAIR, WR ;
HERR, H ;
MORSE, M ;
SOGANI, P ;
WHITMORE, W .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (08) :1231-1238
[3]   THE ROLE OF SURGERY FOLLOWING CHEMOTHERAPY IN STAGE-III GERM-CELL NEOPLASMS [J].
BRACKEN, RB ;
JOHNSON, DE ;
FRAZIER, OH ;
LOGOTHETIS, CJ ;
TRINDADE, A ;
SAMUELS, ML .
JOURNAL OF UROLOGY, 1983, 129 (01) :39-43
[4]   Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testis [J].
Brenner, PC ;
Herr, HW ;
Morse, MJ ;
Sheinfeld, J ;
Aprikian, A ;
Bosl, GJ ;
Motzer, RJ ;
Bajorin, DF ;
Schantz, S ;
Fair, WR ;
Burt, M .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (06) :1765-1769
[5]  
CARSKY S, 1992, International Urology and Nephrology, V24, P305, DOI 10.1007/BF02549540
[6]  
DEVESA SS, 1995, J NATL CANCER I, V2, P970
[7]   CORRELATION OF COMPUTERIZED TOMOGRAPHIC CHANGES AND HISTOLOGICAL-FINDINGS IN 80 PATIENTS HAVING RADICAL RETROPERITONEAL LYMPH-NODE DISSECTION AFTER CHEMOTHERAPY FOR TESTIS CANCER [J].
DONOHUE, JP ;
ROWLAND, RG ;
KOPECKY, K ;
STEIDLE, CP ;
GEIER, G ;
NEY, KG ;
EINHORN, L ;
WILLIAMS, S ;
LOEHRER, P .
JOURNAL OF UROLOGY, 1987, 137 (06) :1176-1179
[8]  
EINHORN LH, 1981, CANCER, V48, P904, DOI 10.1002/1097-0142(19810815)48:4<904::AID-CNCR2820480407>3.0.CO
[9]  
2-O
[10]   EVALUATION OF OPTIMAL DURATION OF CHEMOTHERAPY IN FAVORABLE-PROGNOSIS DISSEMINATED GERM-CELL TUMORS - A SOUTHEASTERN-CANCER-STUDY-GROUP PROTOCOL [J].
EINHORN, LH ;
WILLIAMS, SD ;
LOEHRER, PJ ;
BIRCH, R ;
DRASGA, R ;
OMURA, G ;
GRECO, FA .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (03) :387-391